| Literature DB >> 16237130 |
A Videnovic1, I Semenov, R Chua-Adajar, L Baddi, D T Blumenthal, A C Beck, T Simuni, S Futterer, W Gradishar, C Tellez, J J Raizer.
Abstract
Capecitabine is used to treat advanced breast and gastrointestinal malignancies. A single case of encephalopathy and three cases of peripheral neuropathy are the only neurotoxicities reported. The authors report five additional cases of capecitabine-induced multifocal leukoencephalopathy.Entities:
Mesh:
Substances:
Year: 2005 PMID: 16237130 DOI: 10.1212/01.wnl.0000187313.83515.7e
Source DB: PubMed Journal: Neurology ISSN: 0028-3878 Impact factor: 9.910